MedPath

Curcumin and/or omega-3 polyunsaturated fatty acids supplementation in diabetes mellitus

Phase 3
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20161022030424N5
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

> 18 years old
Diagnosed as having T2DM based on the criterion of the American Diabetes Association
At least moderately controlled diabetes (%5/8>HbA1c)
A stable anti-diabetic drug regimen (over 4 months) before starting the study

Exclusion Criteria

Omega 3 fatty acids supplement intake
Multivitamin-mineral supplements or medicinal products that interfere with patients' lipid profile
Cancer and any chronic disease other than diabetes
Pregnancy and lactation
Smoking
Drinking

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath